Regulus Therapeutics Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Volatile ride for Regulus Therapeutics Inc. stock price on Thursday moving between $2.49 and $2.90
(Updated on May 02, 2024)
The Regulus Therapeutics Inc. stock price gained 7.17% on the last trading day (Thursday, 2nd May 2024), rising from $2.51 to $2.69. During the last trading day the stock fluctuated 16.47% from a day low at $2.49 to a day high of $2.90. The price has risen in 7 of the last 10 days and is up by 21.17% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 147 thousand more shares were traded than the day before. In total, 710 thousand shares were bought and sold for approximately $1.91 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 72.31% during the next 3 months and, with a 90% probability hold a price between $3.89 and $5.94 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
RGLS Signals & Forecast
The Regulus Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.42 and $2.54. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -6.60%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Regulus Therapeutics Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $2.45 and $2.43. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Regulus Therapeutics Inc. finds support just below today's level at $2.45. If this is broken, then the next support from accumulated volume will be at $2.43 and $2.36.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.410 between high and low, or 16.47%. For the last week, the stock has had daily average volatility of 13.32%.
Our recommended stop-loss: $2.57 (-4.59%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 24 days ago.)
Trading Expectations (RGLS) For The Upcoming Trading Day Of Friday 3rd
For the upcoming trading day on Friday, 3rd we expect Regulus Therapeutics Inc. to open at $2.69, and during the day (based on 14 day Average True Range), to move between $2.44 and $2.94, which gives a possible trading interval of +/-$0.250 (+/-9.30%) up or down from last closing price. If Regulus Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 18.60% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.78 (3.35%) than the support at $2.45 (9.11%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
Regulus Therapeutics Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.150. We will update the financials statements for Regulus Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.89% in the first trading day after earnings release.
Is Regulus Therapeutics Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Regulus Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 2.812 Buy Candidate Upgraded
Predicted Opening Price for Regulus Therapeutics Inc. of Friday, May 3, 2024
| Fair opening price May 3, 2024 | Current price |
|---|---|
| $2.69 ( 0.124%) | $2.69 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for RGLS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.10 | 15.37 % | |
| R2 | 2.95 | 9.54 % | ||
| R1 | 2.85 | 5.95 % | ||
| Current price: | 2.69 | |||
| Support | S1 | 2.54 | -5.70 % | |
| S2 | 2.44 | -9.30 % | ||
| S3 | 2.28 | -15.12 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.88 | 7.06 % | |
| R2 | 2.80 | 4.09 % | ||
| R1 | 2.78 | 3.35 % | ||
| Current price | 2.69 | |||
| Support | S1 | 2.45 | -9.11% | |
| S2 | 2.43 | -9.67% | ||
| S3 | 2.36 | -12.27% |
FAQ
Click here for our free guide on how to buy Regulus Therapeutics Inc. Stock.
